Computational drug design of novel COVID-19 inhibitor

BACKGROUND: In 2003, the first case of severe acute respiratory syndrome coronavirus (SARS-CoV) was recorded. Coronaviruses (CoVs) have caused a major outbreak of human fatal pneumonia. Currently, there is no specific drug or treatment for diseases caused by SARS CoV 2. Computational approach that a...

Descripción completa

Detalles Bibliográficos
Autores principales: Arthur, David Ebuka, Elegbe, Benjamin Osebi, Aroh, Augustina Oyibo, Soliman, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284480/
https://www.ncbi.nlm.nih.gov/pubmed/35854796
http://dx.doi.org/10.1186/s42269-022-00892-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284480/
https://www.ncbi.nlm.nih.gov/pubmed/35854796
http://dx.doi.org/10.1186/s42269-022-00892-z

Ejemplares similares